VTE risk raised in first 3-6 months of testosterone treatment

Relative risk 63% higher in current users – but absolute risk fairly low and falls after 6 months Related items from OnMedica Clinical trials needed on safety of testosterone Statins may slow prostate cancer progression in advanced disease Testosterone levels recover after obesity surgery Testosterone for menopausal women Extending anticoagulation duration cuts risk of VTE recurrence

via OnMedica News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/2gLxuA1